Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | USP2 | O75604 | 5/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | SHBG | P04278 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | APAF1 | O14727 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | RAD52 | P43351 | 3/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.42 |
| ▸ | FYN | P06241 | 2/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22939374 | 0.84 | CYP3A4 (0.61) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL29359892 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL16198907 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL28476646 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL20168125 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL29496925 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL2961794 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL1091879 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| SCHEMBL13932430 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 | |
| Octoxynol 9 SCHEMBL29350411 | 0.81 | CYP3A4 (0.82) | CYP3A4SMN1; SMN2LMNAUSP2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4192806-A1 | METHODS FOR PREPARING AND PURIFYING ENVIRONMENTALLY COMPATIBLE DETERGENTS | Takeda Pharmaceutical Company Limited (JP) | 2023-06-14 | — | — | EP | disclosed |
| WO-2022029674-A1 | METHODS FOR PREPARING AND PURIFYING ENVIRONMENTALLY COMPATIBLE DETERGENTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2022-02-10 | — | — | WO | disclosed |
| US-20210032567-A1 | ENVIRONMENTALLY COMPATIBLE DETERGENTS FOR INACTIVATION OF LIPID-ENVELOPED VIRUSES | BAXALTA INCORPORATED (US) | 2021-02-04 | — | — | US | disclosed |
| EP-3704178-A1 | ENVIRONMENTALLY COMPATIBLE DETERGENTS FOR INACTIVATION OF LIPID-ENVELOPED VIRUSES | Baxalta GmbH (CH) | 2020-09-09 | — | — | EP | disclosed |
| CN-111511800-A | Environmentally compatible detergents for inactivation of lipoenveloped viruses | 百深有限责任公司 | 2020-08-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032567-A1 | ENVIRONMENTALLY COMPATIBLE DETERGENTS FOR INACTIVATION OF LIPID-ENVELOPED VIRUSES | ABHD16A, LIPG, ABHD11 | CYP3A4 1914/4885SMN1; SMN2 3705/4885LMNA 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.